Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 91 AL 105

MALDI Mass Spectrometry Imaging in Alzheimer's Disease Lipidomics: Matrix Selection, Spatial Lipid Pathology and Emerging Analytical Strategies

Aebisher D, Krzysztofińska A, Smolak B, Bernat P, Czajka W, Kowal M, Krasoń S, Dynarowicz K, Guz W, Bartusik-Aebisher D.

Int J Mol Sci. 2026 Aug 7;27(16):7074. doi: 10.3390/ijms27167074.

Stage-Dependent Cognitive Effects of a Multinutrient Intervention in Alzheimer's Disease: A Stage-Stratified Meta-Analysis

Han P, Dong P, Zhou Y, Zhang L, Mahomed O.

J Vis Exp. 2026 Sep 1;(235). doi: 10.3791/72385.

Expert opinion on Alzheimer's disease diagnostics and management in Central Eastern European countries representing 88 million population

Mimica N, Dumitrescu L, Gregorič Kramberger M, Hort J, Kovács T, Popadić K, Popescu BO, Rakuša M, Rejdak K, Turčáni P.

Neurol Sci. 2026 Sep 9;47(10):768. doi: 10.1007/s10072-026-09386-6.

[Antibody therapy in Alzheimer's disease]

Schnieder M.

Z Gerontol Geriatr. 2026 Oct;59(6):522-530. doi: 10.1007/s00391-026-02640-8. Epub 2026 Sep 9.

Diagnostic accuracy of a self-administered digital cognitive test battery for differentiating early Alzheimer's disease from controls

Rutt S, Tegethoff P, Taute M, Neziraj F, Hufnagel A, Perneczky R, Kurz C, Rauchmann BS.

Eur Arch Psychiatry Clin Neurosci. 2026 Oct;276(7):3835-3846. doi: 10.1007/s00406-026-02347-2. Epub 2026 Aug 17.

Amyloid-Related Imaging Abnormalities Summit Special Proceedings: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease

Greenberg SM, Iadecola C, Chou SH, Cogswell PM, Elkind MSV, Hicks WJ, Le C, Levine DA, Lipton R, Massimo L, Mohl SM, Seshadri S, Snyder HM, Yaffe K, Zachrison KS; ARIA Summit Working Group.

J Am Heart Assoc. 2026 Sep;15(17):e048108. doi: 10.1161/JAHA.125.048108. Epub 2026 Aug 20.

Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations

Sarangal M, Sarangal C, Vora J, Soni K.

Psychopharmacol Bull. 2026 Sep 18;56(4 Suppl 1):82-87. doi: 10.64719/pb.20773.

Lesion-Level Subtypes of White Matter Hyperintensity Evolution Beyond Spatial Location

Gonzalez-Gomez R, Tagliazuchi E, Campo CG, Medel V, Bennett DA, Iturria-Medina Y.

Neurology. 2026 Sep 22;107(6):e218472. doi: 10.1212/WNL.0000000000218472. Epub 2026 Aug 27.

Efficacy of Brexpiprazole on Neuropsychiatric Symptoms and Impact on Caregivers: Pooled Neuropsychiatric Inventory (NPI) Analysis in Patients With Agitation Associated With Dementia due to Alzheimer's Disease

Grossberg GT, Sabbagh MN, Chumki SR, Wang D, Such P, Zhang Z, Palma AM, Cummings JL.

J Geriatr Psychiatry Neurol. 2026 Sep;39(5):589-601. doi: 10.1177/08919887251407124. Epub 2025 Dec 24.

Stage-dependent relationship between sleep duration and cortical tau deposition in cognitively impaired individuals: A cross-sectional study

Zheng Y, Kang L, Yang X, Zhou R, Chen H, Wang W, Xu X, Xu W, Liu J, Li B, Deng Y.

J Alzheimers Dis. 2026 Aug;112(4):1931-1944. doi: 10.1177/13872877261462419. Epub 2026 Jul 1.

Transcriptome-wide association analysis of Alzheimer's disease: construction and clinical validation of transcriptomic risk scores

Zhang PF, Juan Z, Han J, Wang Y, Zhu T, Pang D, Zheng X, Lu Z.

Eur Arch Psychiatry Clin Neurosci. 2026 Oct;276(7):3765-3775. doi: 10.1007/s00406-026-02338-3. Epub 2026 Aug 17.

A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias

Dubbelman MA, Hill-Jarrett TG, Chapman S, Alves Andrade Dos Santos G, Azar M, Babulal GM, Bell TR, Bernard MA, Boza-Calvo C, Briggs AQ, Bubu OM, Cuevas HE, Dowling NM, Esiaka DK, Fausto BA, de Oliveira FF, Franz CE, Furlano JA, Gonzalez-Corona C, Guest MA, Gupta VB, Gupta VK, Jackson D, Joyce JL, Kann MR, Kremen WS, Lee A, Martinez JE, Masurkar AV, McLin MA, Resende EPF, Rahemi Z, Renfro BC, Aliberti MJR, Shagalow S, Slachevsky A, Talarico JNS, Trani JF, Van Hulle C, Waltrip L, Wandera SO, Windon CC, Yassuda MS, Moretti DV, Kuhn E, Butterbrod E, Gifford KA, Sikkes SAM, Castilhos RM, Nosheny R, Stites SD; a collaboration of the Alzheimer's Association International Society to Advance Alzheimer's Research and Therapy Subjective Cognitive Decline and Diversity and Disparities Professional Interest Areas.

Alzheimers Dement. 2026 Sep;22(9):e71779. doi: 10.1002/alz.71779.

Can the integration of blood-based biomarkers into Alzheimer's disease diagnosis revolutionize the field?

Gaetani L, Nardi G, Parnetti L.

Expert Rev Neurother. 2026 Sep;26(9):839-852. doi: 10.1080/14737175.2026.2700246. Epub 2026 Jul 7.

Emerging diagnostic biomarkers and therapeutic targets in Alzheimer's disease

Dineshbhai TK, Rafaliya D, Singh A, Maheshwari S, Lalan M, Chakraborthy GS.

Inflammopharmacology. 2026 Sep;34(9):6003-6034. doi: 10.1007/s10787-026-02341-z. Epub 2026 Aug 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias